Royalty Pharma plc
RPRX
Clasificación en acciones
#895
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Precio por acción
$60.39
Capitalización bursátil
$26.89B
Cambio (1 día)
-0.93%
Cambio (1 año)
63.17%
País
US
Comercio Royalty Pharma plc (RPRX)
Categoría
Healthcare
Historial de dividendos de Royalty Pharma plc (RPRX)
Royalty Pharma plc (símbolo bursátil: RPRX) realizó un total de 23 pagos de dividendos.
La suma de todos los dividendos (ajustados por splits de acciones) es: $4.50
Rentabilidad por dividendo (TTM): 0.0157
La suma de todos los dividendos (ajustados por splits de acciones) es: $4.50
Rentabilidad por dividendo (TTM): 0.0157
Pagos de dividendos de Royalty Pharma plc (RPRX) desde 2020 hasta 2026
Pagos anuales de dividendos
| Año | Dividendo (ajustado por splits de acciones) | Cambiar |
|---|---|---|
| 2026 (TTM) | $0.235 | -73.30% |
| 2025 | $0.88 | 4.76% |
| 2024 | $0.84 | 5.00% |
| 2023 | $0.8 | 5.26% |
| 2022 | $0.76 | 11.76% |
| 2021 | $0.68 | 126.67% |
| 2020 | $0.3 | 0.00% |
Lista de todos los pagos de dividendos
| Año | Dividendo | Cambiar |
|---|---|---|
| 2026 (TTM) | $0.235 | -73.30% |
| 2025 | $0.88 | 4.76% |
| 2024 | $0.84 | 5.00% |
| 2023 | $0.8 | 5.26% |
| 2022 | $0.76 | 11.76% |
| 2021 | $0.68 | 126.67% |
| 2020 | $0.3 | 0.00% |
Pagos de dividendos de empresas similares o competidoras
| Empresa | Número de pagos de dividendos | País |
|---|---|---|
| 0.00% |
SE
|
|
| 0.00% |
FR
|
|
| 0.00% |
IT
|
|
| 0.00% |
US
|
|
| 69.00% |
HK
|
